NCT00886496View on ClinicalTrials.gov

Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2006

Study Completion Date

April 30, 2011

Conditions
Fever, Sweats, and Hot FlashesInfectionLeukemiaLymphomaMyelodysplastic SyndromesNeutropeniaUnspecified Childhood Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

recombinant human mannose-binding lectin

Trial Locations (3)

19104

Children's Hospital of Philadelphia, Philadelphia

92868

Children's Hospital of Orange County, Orange

20010-2970

Children's National Medical Center, Washington D.C.

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Enzon Pharmaceuticals, Inc.

INDUSTRY